The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Levine Jon R since 2019.
This trader's CIK number is 1789645.
At the time of last reporting, Levine Jon R was the President and CEO of Marimed Inc.. (stock ticker symbol MRMD).
Also see all insider trading activities at Marimed Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | MRMD | 0 | $0 | 0 | $0 | 211,233 | $0 |
| 2024 | MRMD | 0 | $0 | 50,031 | $12,757 | 451,111 | $0 |
| 2023 | MRMD | 0 | $0 | 90,983 | $31,971 | 277,778 | $0 |
| 2021 | MRMD | 0 | $0 | 0 | $0 | 100,000 | $63,000 |
| 2020 | MRMD | 0 | $0 | 0 | $0 | 350,000 | $49,000 |
| 2017 | MRMD | 19,495,000 | $0 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-15 | MRMD | Option Ex | 89,859 | .00 | 0 |
| 2025-05-07 | MRMD | Option Ex | 75,000 | .00 | 0 |
| 2025-04-02 | MRMD | Option Ex | 23,041 | .00 | 0 |
| 2025-03-07 | MRMD | Option Ex | 23,333 | .00 | 0 |
| 2024-11-07 | MRMD | Option Ex | 150,000 | .00 | 0 |
| 2024-10-27 | MRMD | Option Ex | 138,889 | .00 | 0 |
| 2024-09-07 | MRMD | Option Ex | 23,333 | .00 | 0 |
| 2024-04-29 | MRMD | Sale | 50,031 | .26 | 12,757 |
| 2024-04-27 | MRMD | Option Ex | 138,889 | .00 | 0 |
| 2023-10-27 | MRMD | Option Ex | 138,889 | .00 | 0 |
| 2023-10-27 | MRMD | Sale | 41,590 | .32 | 13,350 |
| 2023-04-27 | MRMD | Option Ex | 138,889 | .00 | 0 |
| 2023-04-28 | MRMD | Sale | 49,393 | .38 | 18,621 |
| 2021-12-28 | MRMD | Option Ex | 100,000 | .63 | 63,000 |
| 2020-11-17 | MRMD | Option Ex | 350,000 | .14 | 49,000 |
| 2017-06-30 | MRMD | Buy | 19,495,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Levine Jon R (President and CEO of Marimed Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.